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**Value of the data**•Rapid detection is crucial for Coxsackievirus A10 control along with the increasing circulation worldwide in the recent years.•Specific and conserved regions for primers and probe design are defined using multiple sequence alignment.•The intra- and inter-assay reproducibility are assessed using different concentrations of plasmid DNA and viral RNA.

1. Data {#s0005}
=======

Using TaqMan probes we have previously established a real time RT-PCR method for Coxsackievirus A10 and other enterovirus detection [@bib1].

The data presented in this article show the conserved regions for primers and probe design using multiple sequence alignment ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}). [Table 1](#t0005){ref-type="table"} represents data of the average threshold cycle (Ct) value, standard deviation (SD) and the coefficient of variability (CV) of different concentrations of plasmid DNA and viral RNA.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Primers and probes design {#s0015}
------------------------------

Sequences of CV-A10 VP1 gene and 5′-NCR of different enterovirus serotypes were downloaded from NCBI (<http://www.ncbi.nlm.nih.gov/>) database. Multiple sequences alignment was performed using the Clustal W algorithm in MEGA 5.2 software. Primer Express software (version 3.0; Applied Biosystems) was used to design the primers and probe for CV-A10 assay based on their highly conserved and specific regions ([Fig. 1](#f0005){ref-type="fig"}). For EVs detection, the primers and probe were chosen according to previous studies [@bib2], [@bib3]; A small amplicon of 142 nucleotides in size were produced ([Fig. 2](#f0010){ref-type="fig"}). All oligonucleotides were synthesized by TAKARA (Dalian, China).

2.2. Standard plasmid DNA construction {#s0020}
--------------------------------------

To facilitate viral quantification, plasmids containing the target genes were constructed. The targeted gene segments were amplified and purified, and then cloned into the pMD-18 Vector by using the T-A clone kit (TaKaRa, Dalian, China). Constructed plasmid containing amplified segments were purified and sequenced in both directions. The standard plasmid concentration were quantified and the genome copies were calculated by as follows: copy number=\[(plasmid concentration)/(molarmass)\]×(6.02×10^23^).

2.3. Repeatability and reproducibility of the assay {#s0025}
---------------------------------------------------

To assess the intra- and inter-assay reproducibility, 2.0×10^6^, 2.0×10^3^ and 2.0×10^1^ of plasmid DNA were diluted; Viral RNA from a CV-A10 clinical sample was extracted using the QIAamp viral RNA mini kit (Qiagen, Hilden, Germany) according to the manufacturer׳s instructions and the equivalent RNA copies were calculated. The intra-assay variation was assessed with the samples in triplicate and the inter-assay variation was determined by three independent runs. The reproducibility was then analyzed based on the standard deviation (SD) and the coefficient of variability (CV) of the Ct average ([Table 1](#t0005){ref-type="table"}).
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###### 

Intra- and inter-assay variations in different concentrations of plasmid DNA and viral RNA.

Table 1

  Copy number                      Intra-assay variation   Inter-assay variation                         
  -------------------------------- ----------------------- ----------------------- ------ ------- ------ ------
  duplex rRT-PCR of EV assay                                                                             
  Plasmid DNA                                                                                            
  2.0×10^6^                        19.31                   0.14                    0.74   19.28   0.42   2.19
  2.0×10^3^                        29.18                   0.09                    0.33   29.36   0.46   1.57
  2.0×10^1^                        36.16                   0.37                    1.02   36.26   0.95   2.62
  Viral RNA                                                                                              
  2.5×10^7^                        20.59                   0.02                    0.11   20.22   0.31   1.26
  1.0×10^6^                        23.02                   0.09                    0.39   22.78   0.39   1.72
  4.0×10^4^                        25.65                   0.06                    0.24   25.19   0.41   1.64
                                                                                                         
  duplex rRT-PCR of CV-A10 assay                                                                         
  Plasmid DNA                                                                                            
  2.0×10^6^                        20.18                   0.21                    1.04   19.63   0.37   1.88
  2.0×10^3^                        29.77                   0.19                    0.63   29.19   0.61   2.09
  2.0×10^1^                        37.09                   0.59                    1.58   36.19   0.49   1.34
  Viral RNA                                                                                              
  2.5×10^7^                        19.74                   0.03                    0.13   19.89   0.28   1.39
  1.0×10^6^                        22.14                   0.06                    0.28   22.45   0.35   1.57
  4.0×10^4^                        24.54                   0.08                    0.31   24.82   0.34   1.37
